Federico Mingozzi

Federico Mingozzi

Company: Spark Therapeutics

Job title: CSO

Seminars:

Industry Leaders Panel: Accelerating Gene Therapies for Rare Disease Patients – Where are the Bottlenecks & How Can we Overcome Them? 9:30 am

Gene therapy continues to make significant progress with no signs of slowing down, but the past year has also flagged distinct development challenges that need to be overcome. This panel discussion will bring together experts from pioneering gene therapy companies leading the way to pinpoint these obstacles and explore how we can address them to…Read more

day: Day One

Chair’s Closing Remarks 3:00 pm

Read more

day: Post-Conference Discussion Day - Track A

PANEL DISCUSSION: Where are the Biggest Bottlenecks for Gene Therapy Immunogenicity & Which Approaches are Showing Most Promise (and Feasibility)? 2:30 pm

Actively minimizing immunogenic responses How close are we to redosing? Widening patient eligibility in relation to antibody positivity Exploring innovative vector modificationsRead more

day: Post-Conference Discussion Day - Track A

Chair’s Opening Remarks 9:15 am

Read more

day: Post-Conference Discussion Day - Track A

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.